Bill Text: DE SB137 | 2009-2010 | 145th General Assembly | Draft
Bill Title: An Act To Amend Title 14 Of The Delaware Code Relating To The Delaware State University Board Of Trustees
Spectrum: Partisan Bill (Democrat 4-0)
Status: (Introduced - Dead) 2009-06-04 - Assigned to Education Committee in Senate [SB137 Detail]
Download: Delaware-2009-SB137-Draft.html
SPONSOR: |
Sen. Henry & Rep. Barbieri |
|
Sens. Blevins, Hall-Long & Peterson; Reps. Q. Johnson, Keeley, D.E. Williams & Bolden |
DELAWARE STATE SENATE 146th GENERAL ASSEMBLY |
SENATE BILL NO. 137 |
AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO COST-SHARING, DEDUCTIBLE OR CO-INSURANCE FOR TIER IV OR SPECIALTY TIER PRESCRIPTION DRUGS. |
WHEREAS, traditional prescription drug benefit plans include a multi-tiered drug formulary structure. Generic drugs are in the first tier, preferred brand name drugs are in tier two, and non-preferred brand drugs are in tier three, for example. Specialty tiers are typically the fourth or greater tier; and
WHEREAS, specialty tier are commonly prescription drugs to treat conditions such as hemophilia, human immunodeficiency virus (HIV), hepatitis, multiple sclerosis, lupus, some cancers, rheumatoid arthritis, and others; and
WHEREAS, the specialty tier changes the patient's cost from a fixed copayment to a coinsurance as a percent of the cost of the drug; and
WHEREAS, a patient may pay a copayment which is increased with each tier but is a fixed amount for medications on the lower tiers of an insurance formulary; and
WHEREAS, the specialty tiers require the patient to pay a coinsurance or percentage (20-30% or more) of the drug cost;
NOW THEREFORE:
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:
Section 1. Amend Title 18 of the Delaware Code by adding a new §3761 to read as follows:
"3361. Specialty Tier Prescription Moratorium and Study.
No health care plan or health insurance policy which provides coverage for prescription drugs and for which cost-sharing, deductibles or co-insurance obligations are determined by category of prescription drugs including, but not limited to, generic drugs, preferred brand drugs and non-preferred brand drugs, shall impose cost-sharing, deductibles or co-insurance obligations for any prescription drug that exceeds the dollar amount of cost-sharing, deductibles or co-insurance obligations for any other prescription drug provided under such coverage in the category of non-preferred brand drugs or their equivalents for a period of one year ending July 1, 2012.
The Delaware Healthcare Commission shall conduct a study for specialty tier prescription drugs to determine the impact on access and patient care. The Delaware Healthcare Commission shall submit a report to the General Assemble summarizing this impact by March 15, 2012."
SYNOPSIS
This Bill creates a moratorium on health insurance providers that charge higher cost sharing for different classification of prescription drugs. |
Author:Senator Henry